Titan Pharmaceuticals Inc (NASDAQ:TTNP)
| 0.76 BATS BZX Real-Time Price As of 2:35pm ET |  -0.0129 / -1.67%Today’s Change | 0.35 Today|||52-Week Range 1.59 | -2.95% Year-to-Date |
Latest TTNP News | Press Releases
No recent news for Titan Pharmaceuticals Inc.
Today’s Trading
| Previous close | 0.77 |
| Today’s open | 0.76 |
| Day’s range | 0.76 - 0.76 |
| Volume | 104 |
| Average volume (3 months) | 35,577 |
| Market cap | $11.7M |
Data as of 2:35pm ET, 03/22/2023
Growth & Valuation
| Earnings growth (last year) | +81.34% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -68.46% |
| P/E ratio | NM |
| Price/Sales | 6.50 |
| Price/Book | 1.54 |
Competitors
| ---- | ||
| TOVXTheriva Biologics In... | -0.04 | -5.14% |
| AGRXAgile Therapeutics I... | +0.02 | +7.29% |
| NAVBNavidea Biopharmaceu... | -0.01 | -2.21% |
Data as of 3:03pm ET, 03/22/2023
Financials
| Last reporting date | August 17, 2022 |
| EPS forecast (this quarter) | -$0.26 |
| Annual revenue (last year) | $1.5M |
| Annual profit (last year) | -$8.8M |
| Net profit margin | -575.10% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
